
Zimmer Biomet Holdings, Inc.: updates and filings
Price
$101.10
November 20, 2026Market cap $19.8B
What Ploutos Investor adds for Zimmer Biomet
Part of Ploutos Investor, €9.99 a month
- The full history: 17 fiscal years, from 2009
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
last Nov 4, 2026next Feb 4, 2027
An estimate from when it has reported before, which has been regular. The company announces the date itself.
November 2026
August 2026
May 2026
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 13, 2026Exchange certification of a listingFormCERT
- Nov 12, 2026Securities listed on an exchangeForm8-A12B
- Nov 12, 2026Material agreement entered, new material financial obligationForm8-K
- Nov 4, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Nov 4, 2026Results of operationsForm8-K
- Sep 8, 2026Officer or director change, Regulation FD disclosureForm8-K
- Aug 13, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Aug 12, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Aug 5, 2026Other material eventsForm8-K
- Aug 5, 2026Quarterly reportfor the period to Jun 30, 2026Form10-Q
- Aug 5, 2026Results of operationsForm8-K
- Jun 29, 2026Material agreement entered, material agreement ended, new material financial obligationForm8-K
- May 27, 2026Shareholder voteForm8-K
- May 27, 2026Conflict minerals reportFormSD
- May 15, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- May 12, 2026Regulation FD disclosureForm8-K
- May 1, 2026Quarterly reportfor the period to Mar 31, 2026Form10-Q
- Apr 30, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Apr 28, 2026Officer or director change, Regulation FD disclosureForm8-K
- Apr 28, 2026Results of operationsForm8-K
- Apr 1, 2026Annual report to shareholdersfor the period to Dec 31, 2025FormARS
- Apr 1, 2026Additional annual meeting materialFormDEFA14A
- Apr 1, 2026Annual meeting proxy statementFormDEF 14A
- Mar 27, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Feb 20, 2026Annual reportfor the period to Dec 31, 2025Form10-K
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 13, 2026 | CERT | Exchange certification of a listing | Document |
| Nov 12, 2026 | 8-A12B | Securities listed on an exchange | Document |
| Nov 12, 2026 | 8-K | Material agreement entered, new material financial obligation | Document |
| Nov 4, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Nov 4, 2026 | 8-K | Results of operations | Document |
| Sep 8, 2026 | 8-K | Officer or director change, Regulation FD disclosure | Document |
| Aug 13, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Aug 12, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Aug 5, 2026 | 8-K | Other material events | Document |
| Aug 5, 2026 | 10-Q | Quarterly reportfor the period to Jun 30, 2026 | Document |
| Aug 5, 2026 | 8-K | Results of operations | Document |
| Jun 29, 2026 | 8-K | Material agreement entered, material agreement ended, new material financial obligation | Document |
| May 27, 2026 | 8-K | Shareholder vote | Document |
| May 27, 2026 | SD | Conflict minerals report | Document |
| May 15, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| May 12, 2026 | 8-K | Regulation FD disclosure | Document |
| May 1, 2026 | 10-Q | Quarterly reportfor the period to Mar 31, 2026 | Document |
| Apr 30, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Apr 28, 2026 | 8-K | Officer or director change, Regulation FD disclosure | Document |
| Apr 28, 2026 | 8-K | Results of operations | Document |
| Apr 1, 2026 | ARS | Annual report to shareholdersfor the period to Dec 31, 2025 | Document |
| Apr 1, 2026 | DEFA14A | Additional annual meeting material | Document |
| Apr 1, 2026 | DEF 14A | Annual meeting proxy statement | Document |
| Mar 27, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Feb 20, 2026 | 10-K | Annual reportfor the period to Dec 31, 2025 | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC since Mar 26, 2001: every report, 8-K, meeting and letter. Of its other filings (923 in all), the newest. Of its note and share prospectuses (424B, FWP), the newest 40 of 59.
The full analysis
What do Zimmer Biomet's filings show?
The filings are where every one of Zimmer Biomet's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.